Meadowbrook Advisors Group LLC Purchases Shares of 7,930 CME Group Inc. $CME

Posted by Brian Himes on Jun 20th, 2026

Meadowbrook Advisors Group LLC purchased a new position in CME Group Inc. (NASDAQ:CME – Free Report) in the fourth quarter, HoldingsChannel reports. The institutional investor purchased 7,930 shares of the financial services provider’s stock, valued at approximately $2,166,000. CME Group makes up about 1.2% of Meadowbrook Advisors Group LLC’s holdings, making the stock its 25th largest position.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. Asset Dedication LLC increased its position in shares of CME Group by 64.9% in the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 37 shares during the period. FNY Investment Advisers LLC acquired a new stake in CME Group during the 4th quarter worth about $27,000. Elkhorn Partners Limited Partnership acquired a new stake in CME Group during the 4th quarter worth about $27,000. Hilton Head Capital Partners LLC purchased a new stake in CME Group during the 4th quarter valued at about $28,000. Finally, Legacy Wealth Managment LLC ID grew its stake in CME Group by 191.9% during the 4th quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock valued at $29,000 after purchasing an additional 71 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Key Stories Impacting CME Group

Here are the key news stories impacting CME Group this week:

Positive Sentiment: CME continues to be highlighted as a dividend and value stock, with analysts noting its strong capital returns, electronic trading growth, and global product expansion could support a long-term rebound. Article Title
Positive Sentiment: One market note said CME may be undervalued after the CEO succession announcement, suggesting the stock could have upside if investors view the leadership transition as orderly. Article Title
Neutral Sentiment: CME named longtime finance chief Julie Winkler as its next CEO, while Terry Duffy will step into an executive chairman role; the move appears planned and may reduce uncertainty, but it also marks a major leadership change. Article Title
Neutral Sentiment: The company is also taking legal action against the CFTC over approval of perpetual crypto futures, arguing the products should be treated as swaps rather than futures. The case could affect CME’s role in crypto derivatives, but the financial impact is still uncertain. Article Title
Negative Sentiment: Goldman Sachs kept a Sell rating on CME and trimmed its price target, citing leadership transition risk and regulatory uncertainty, which may be weighing on sentiment. Article Title

CME Group Price Performance

Shares of CME opened at $246.38 on Friday. The company has a market capitalization of $89.28 billion, a price-to-earnings ratio of 21.02, a PEG ratio of 2.75 and a beta of 0.21. CME Group Inc. has a 52 week low of $244.56 and a 52 week high of $329.16. The stock’s 50-day moving average price is $279.61 and its 200-day moving average price is $287.21. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group (NASDAQ:CME – Get Free Report) last announced its quarterly earnings results on Wednesday, April 22nd. The financial services provider reported $3.36 earnings per share for the quarter, beating the consensus estimate of $3.11 by $0.25. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The company had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.77 billion. During the same period last year, the business earned $2.80 earnings per share. CME Group’s quarterly revenue was up 14.5% on a year-over-year basis. On average, sell-side analysts predict that CME Group Inc. will post 12.28 EPS for the current year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th will be paid a dividend of $1.30 per share. The ex-dividend date of this dividend is Tuesday, June 9th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 2.1%. CME Group’s dividend payout ratio (DPR) is presently 44.37%.

Insider Activity at CME Group

In related news, CEO Terrence A. Duffy sold 35,000 shares of the stock in a transaction on Friday, May 15th. The shares were sold at an average price of $298.51, for a total transaction of $10,447,850.00. Following the sale, the chief executive officer directly owned 55,630 shares of the company’s stock, valued at approximately $16,606,111.30. This represents a 38.62% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Hilda Harris Piell sold 5,753 shares of the firm’s stock in a transaction on Monday, May 18th. The shares were sold at an average price of $304.63, for a total transaction of $1,752,536.39. Following the sale, the insider owned 27,702 shares in the company, valued at approximately $8,438,860.26. This represents a 17.20% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.30% of the stock is owned by insiders.

Analyst Ratings Changes

A number of brokerages have recently weighed in on CME. Morgan Stanley cut their price objective on CME Group from $362.00 to $353.00 and set an “overweight” rating on the stock in a report on Thursday, April 23rd. Weiss Ratings lowered CME Group from a “buy (a-)” rating to a “buy (b+)” rating in a research report on Thursday, June 11th. Barclays cut their price target on shares of CME Group from $343.00 to $316.00 and set an “equal weight” rating on the stock in a report on Thursday, April 23rd. Raymond James Financial lifted their price objective on shares of CME Group from $310.00 to $320.00 and gave the company an “outperform” rating in a research note on Monday, April 6th. Finally, Piper Sandler set a $320.00 price objective on shares of CME Group in a research note on Wednesday. Twelve investment analysts have rated the stock with a Buy rating, four have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, CME Group has a consensus rating of “Moderate Buy” and a consensus price target of $305.18.

Read Our Latest Stock Analysis on CME

CME Group Company Profile

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.